Literature DB >> 25188760

Home blood pressure is the predictor of subclinical target organ damage like ambulatory blood pressure monitoring in untreated hypertensive patients.

Ae Young Her1, Yong Hoon Kim, Se Joong Rim, Jong Youn Kim, Eui Young Choi, Pil Ki Min, Byoung Kwon Lee, Bum Kee Hong, Hyuck Moon Kwon.   

Abstract

OBJECTIVE: Home blood pressure (HBP) measurements are known as an important adjunct to office blood pressure (OBP) measurements in clinical practice. But little is known about the relationship between HBP and subclinical target organ damage (TOD) other than left ventricular hypertrophy (LVH). So we investigated the relationship of HBP measurements with subclinical TOD in untreated hypertensive patients.
METHODS: We measured ambulatory blood pressure (ABP), HBP and OBP of 93 untreated hypertensive patients (men: 60 and women: 33, mean age, 49±13 years). The ABP was recorded for 24 hours, HBP was measured for one week, and OBP was measured at least in two visits. All BP measurements were taken using automatic BP measuring device. The parameters indicating subclinical TOD were the left-ventricular mass index (LVMI) by transthoracic echocardiography, urinary albumin excretion rate (AER), brachial ankle pulse-wave velocity (PWV), and carotid intima-media thickness (IMT).
RESULTS: The LVMI was significantly correlated with systolic HBP and 24 hours systolic ABP, but not with OBP. The AER, PWV and IMT were also significantly correlated with systolic HBP and 24 hours systolic ABP. In a binary logistic regression analysis, systolic HBP, 24 hours systolic and diastolic ABP were the predictors of LVMI, AER and PWV (all p<0.05).
CONCLUSION: Our data suggest that HBP is as good as ABP monitoring and superior to OBP measurements in regard to their association with subclinical TOD. Therefore, HBP measurements give valuable information on the subclinical TOD in hypertensive patients in addition to ABP monitoring.

Entities:  

Mesh:

Year:  2014        PMID: 25188760     DOI: 10.5152/akd.2014.5119

Source DB:  PubMed          Journal:  Anadolu Kardiyol Derg        ISSN: 1302-8723


  7 in total

Review 1.  Current status of home blood pressure monitoring in Asia: Statement from the HOPE Asia Network.

Authors:  Yook-Chin Chia; Peera Buranakitjaroen; Chen-Huan Chen; Romeo Divinagracia; Satoshi Hoshide; Sungha Park; Jinho Shin; Saulat Siddique; Jorge Sison; Arieska Ann Soenarta; Guru Prasad Sogunuru; Jam Chin Tay; Yuda Turana; Ji-Guang Wang; Lawrence Wong; Yuqing Zhang; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-08-17       Impact factor: 3.738

2.  Provisional criteria for the diagnosis of hypertension in pregnancy using home blood pressure measurements.

Authors:  Yukiko Mikami; Yasushi Takai; Sumiko Era; Yoshihisa Ono; Masahiro Saitoh; Kazunori Baba; Hiromichi Suzuki; Hiroyuki Seki
Journal:  Hypertens Res       Date:  2017-02-09       Impact factor: 3.872

3.  Author's Reply.

Authors:  Ae-Young Her
Journal:  Anatol J Cardiol       Date:  2015-07       Impact factor: 1.596

4.  Could the data of home blood pressure monitoring be used to evaluate the risk of subclinical target organ damage in hypertensive patients?

Authors:  Olga M Posnenkova; Anton R Kiselev
Journal:  Anatol J Cardiol       Date:  2015-07       Impact factor: 1.596

5.  Differences in home blood pressure and pulse rates between singleton and twin pregnancies.

Authors:  Yukiko Mikami; Yasushi Takai; Sumiko Era; Yoshihisa Ono; Masahiro Saitoh; Kazunori Baba; Hiromichi Suzuki; Hiroyuki Seki
Journal:  J Int Med Res       Date:  2018-01-19       Impact factor: 1.671

6.  Circulating CTRP1 Levels Are Increased and Associated with the STOD in Essential Hypertension in Chinese Patients.

Authors:  Zhengjia Su; Shuya Tian; Wei Liang
Journal:  Cardiovasc Ther       Date:  2019-06-02       Impact factor: 3.023

Review 7.  Exploring the Use of Telemonitoring for Patients at High Risk for Hypertensive Disorders of Pregnancy in the Antepartum and Postpartum Periods: Scoping Review.

Authors:  Maria Aquino; Sarah Munce; Janessa Griffith; Maureen Pakosh; Mikayla Munnery; Emily Seto
Journal:  JMIR Mhealth Uhealth       Date:  2020-04-17       Impact factor: 4.773

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.